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Purpose. To compare Ganoderma spores lipid (GSL) and ﬁsh oil (FO) in inhibiting retinal photoreceptor cell lesions induced
by N-methyl-N-nitrosourea (MNU) in rats. Methods. 120 rats were untreated (normal control, NC group) or treated with a
single intraperitoneal injection of 40mg/kg MNU (MNU group) then treated with GSL (GSL group) or FO (FO group). Eyes
were obtained at 1, 3, 5, 7, and 10 days. Results. Light microscopy assay demonstrated that GSL and FO alleviated rat retinal
photoreceptor cell damage (GSL and FO versus MNU group P<. 001) similarly (GSL versus FO group P = .980). Electron
microscopy conﬁrmed that GSL and FO reversed damage to photoreceptor segments and photoreceptor cell nuclei. GSL-treated
rats showed signiﬁcantly elevated a-wave and b-wave amplitudes over MNU group (P<. 05) but less than NC group (P<. 05)
and not signiﬁcantly diﬀerent from FO group (P>. 05). Conclusion. GSL, like FO, alleviates rat retinal photoreceptor cell damage
induced by MNU.
1.Introduction
Retinitis pigmentosa (RP) is a heterologous group of inher-
ited human disorders causing primary retinal degeneration
and functional blindness. The main feature of RP is pro-
gressive damage tothe retinal photoreceptorand pigmentary
epithelium [1]. The incidence of this disease is about 1/4000,
and almost 1.5 million are aﬀected persons worldwide [2].
While eﬀective medicines to treat RP are in various stages of
development,none are generally available.
Anumberofstudiespublishedinrecentyearshaveexam-
ined the potential protective eﬀects of ﬁsh oil (FO) supple-
mentation in ocular disease. FO is an excellent source of n-
3 polyunsaturated fatty acid (PUFA). Both statistically and
clinically, signiﬁcant improvement in visual acuity or stabil-
ity was observed in patients with intermediate age-related
macular degeneration (AMD) treated with a nutritional
supplementrich in n-3 PUFA[3].FO has a therapeuticeﬀect
onthedegenerationof theretinal photoreceptorcell induced
b yl i g h ti na na n i m a lm o d e l[ 4]. Although it has a variety
of health beneﬁts, FO is not always well tolerated. While
t h em o s tc o m m o ns i d ee ﬀects of taking FO supplements
are gastrointestinal upset and ﬁshy aftertaste, and it can also
cause excessive bleeding or heavy metal poisoning [5].
Ganoderma lucidum (G. lucidum Reishi) is a medicinal
mushroom used for centuries in East Asian countries to pro-
mote healthand longevity.However,onlyin thelast tenyears
have Ganoderma lucidum spores (5–12μm) been available
for the same medical purpose as the whole mushroom. More
recently, the lipidstored between the inner and outerwalls of
spores, Ganoderma spores lipid (GSL) has been successfully
extracted from sporoderm-broken germinating spores [6, 7].
Interestingly, GSL concentrates all the bioactive components
of the spores [7, 8], whose bioactive may be much higher
than those of the fruiting body of Ganoderma lucidum [6].
Recent studies have demonstrated the neuroprotective eﬀect
ofGanoderma lucidumtoreduceoxidativestress invitro [9],
to induce neuronal diﬀerentiation [10], and to prevent the
harmful eﬀects of the exterminating toxin Aβ in Alzheimer’s
diseaseinculturedratneurons[11].However,othereﬀectsof2 Evidence-Based Complementary and Alternative Medicine
GSLon the nervoussystemhave not beenexplored, and even
less is known about its eﬀect on retina degenerative diseases.
In our previous study, we found that GSL blocked N-
methyl-N-nitrosourea- (MNU-) induced photoreceptor cell
apoptosis in rats via regulating Bax, Bcl-xl, and caspase-3
[12]. Importantly, GSL contains a great number of PUFAs
[7], just like FO. But the majority composition in GSL is
oleic acid (OA) while in FO is docosahexaenoic acid (DHA).
Both GSL and FO exhibit the protective eﬀects on photo-
receptor cells. So, the purpose of the present research was
to investigate the protective eﬀect of GSL relative to FO in
reversing MNU-induced photoreceptor cell damage in rats.
MNU-induced photoreceptor cell damage in rats pro-
vides a useful model for understanding RP and developing
and evaluating therapeutic interventions [13]. In the present
study, a single intraperitoneal dose of 40mg/kg MNU was
used to induce retina damage and photoreceptor cell loss.
Via electrophysiology and morphology analysis, our ﬁndings
show that GSL has the same eﬀect as FO in alleviating the
extent of rat retinal photoreceptor cell damage induced by
MNU.
2.Materialsand Methods
2.1. Animals and Procedures. One hundred and twenty 50-
day-old female Sprague-Dawley rats were obtained from the
animal facility at the Sun Yat-sen University, Guangzhou,
China. The experiments were conducted in compliance with
the ARVO Statement for the Use of Animals in Ophthalmic
and Vision Research, and thestudy was approvedbythe local
Medical Ethics Committee. Rats were reared under stan-
dard laboratory conditions (22 ± 2◦C, 60% ± 10% relative
humidity and a 12-hr light-dark cycle)and had free access to
food and water throughout the experiment.
The rats were randomly divided into four groups
(Figure 1), including the normal control group (NC group,
n = 30), the untreated MNU model control group (MNU
group, n = 30), the GSL treatment group (GSL group,
n = 30), and the FO treatment group (FO group, n =
30). According to our previous work [12] ,t h ed o s eo fG S L
(BXLC070116,speciﬁcgravity0.9173,HolistolInternational
Ltd., Hong Kong, China) used was 2mg/kg body weight by
intragastric administration once daily. GSL was mixed in
1mL 0.5% hydroxypropyl methyl cellulose (MC) used as the
excipient. Intragastric administration of GSL was performed
each day for the three days before the animal model was
established.One houraftertheadministration ofGSLon day
three, a single intraperitoneal injection of 40mg/kg MNU
(Sigma, St. Louis, Mo) was given to establish the animal
model. MNU, kept at −20◦C in the dark, was dissolved
in PBS to a ﬁnal concentration of 10mg/mL immediately
before use. GSL was consecutively given to animals daily
f o rt e nd a y sa f t e rM N Ui n j e c t i o n .I nt h eN Cg r o u p ,r a t s
received intragastric administration of excipient (1 mL once
daily)instead of GSLand intraperitoneal injection of4ml/kg
PBS instead of MNU compared with the GSL group. In the
MNU group, the excipient (1mL once daily) was intragastric
administrated instead of GSL. In the FO group, rats received
intragastric administration of FO (Incromega DHA 500TG
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Figure 1: Schematic representation of animal groups and exper-
imental protocol. Rats were randomly divided into the normal
control (NC) group (NC group), the untreated N-methyl-N-
nitrosourea (MNU) modelcontrolgroup (MNU group),the Gano-
dermasporeslipid(GSL)treatmentgroup(GSLgroup),andtheﬁsh
oil(FO)treatmentgroup (FOgroup).Weused0.5%hydroxypropyl
methyl cellulose (MC) as the excipient.
￿Intraperitoneal injection
was of 40mg/kg MNU or 4mL/kg PBS. Six rats were sacriﬁced at
each time point after MNU or PBS injection.
S R ,C r o d a ,U K ,2 m g / k go n c ed a i l y )i n s t e a do fG S L .O n e
hour after administration of GSL, or FO, or MC on days 1,
3, 5, 7, and 10 post-MNU or PBS injection in each group,
the left eye of six randomly selected animals was chosen
for electroretinogram (ERG) analysis. The amplitudes of a-
and b-waves were analyzed. After ERG analysis, animals were
sacriﬁced, and right eyes were prepared for analysis by light
microscopy and electromicroscopy.
2.2. Electroretinogram (ERG). As described previously [12],
rats were weighed and dark-adapted for 2hr before ERG
analysis. ERG wavelets were recorded four times, and the
average amplitudes of a- and b-waves were calculated. The
amplitude of the a-wave was measured as the distance
from the baseline to the bottom of the a-wave, while the
amplitude of the b-wave was measured as the distance from
the bottom of the a-wave to the peak of the b-wave. ERGs
were monitoredby electrophysiologicalrecorder(Neuropack
α,NihonKohdenCorp.,Tokyo,Japan)atdiﬀerenttimesafter
MNU injection in each group.
2.3. Light Microscopy Assay. The right eyes were preﬁxed
with 4% paraformaldehyde in PBS at room temperature
for 30min. The eyeballs were sagittally cut into two half-
balls through the optic nerve head. One half was reserved
for electromicroscopy assay (described below). The other
half was ﬁxed in methacarn solution for 24hr [14], and the
lens was extirpated. Next, samples from this half were incu-
bated in 50% ethanol for 1hr, dehydrated, and embedded
routinely, and sagittal sections (4mm thick) were cut near
the optic nerve head. The slices were dewaxed, stained
with haematoxylin for 10min, restained with eosin for 5secEvidence-Based Complementary and Alternative Medicine 3
Table 1: The grading criteria forouter nuclear layer (ONL)damage
induced by MNU.
Grade ONL damage Score
0 Normal appearance 0
1
Distorted nuclear orientation ≤1/2
normal ONL thickness but no apparent
reduction in ONL thickness
1
2
Distorted nuclear orientation >1/2
normal ONL thickness,or cell loss ≤1/4
normal ONL thickness and ≤1/6
complete length of retinal section
2
3
Cell loss of 1/4–1/3 normal ONL
thickness and >1/6 complete length of
retinal section
3
4
Cell loss of 1/3–1/2 normal ONL
thickness and >1/6 complete length of
retinal section
4
5 Cell loss ≥1/2 normal ONL thickness and
>1/6 complete length of retinal section 5
and sealed with neutral gum. The extent of damage to
the retinal photoreceptor cell was observed under optical
microscope (HB-10104A, Nikon Corp., Tokyo, Japan) and
photographed. The extent of retina damage to the outer
nuclearlayer(ONL)wasevaluatedunderthemicroscopeand
was graded on a pathological score scale of 0–5 using criteria
based on the extent of ONL damage as described in Table 1.
2.4. Electromicroscopy Assay. The half of the right eye re-
served for electromicroscopy assay was kept in 2.5% glu-
taraldehyde overnight. The samples were postﬁxed in 2%
osmium solution 20min, then dehydrated and embedded in
epon, and polymerased at 60◦C. Thin sections (50nm thick)
s t a i n e dw i t hu r a n y la c e t a t ea n dl e a dc i t r a t ew e r ee x a m i n e d
using a Tecnai Spirit G2 electron microscope (FEI, Hillsboro,
Ore).
2.5. Statistical Analysis. T h ed a t aw e r ep r e s e n t e da st h e
mean ± standard deviation (SD). Statistical analyses were
performed using one-way ANOVA followed by Bonferroni-
test or Dunnett T3-test employing SPSS version 11.0 (SPSS,
Inc., Chicago, Ill). The signiﬁcance level was set at P<. 05.
3.Results
3.1. GSL Shows the Same Protective Eﬀect with FO on Retina
Function Detected by Electroretinogram. In the MNU group,
both a- and b-wave amplitudes were decreased signiﬁcantly
at each time point compared with the NC group (all P<. 01,
Figures 2(b) and 2(d)). In GSL-treated rats, both a- and
b-wave amplitudes were elevated signiﬁcantly at each time
point compared with the MNU group (P<. 05, Figures 2(b)
and 2(d)) but still lower than the NC group (P<. 05 or .01,
Figures 2(b) and 2(d)). Meanwhile, in FO-treated rats, both
a- and b-wave amplitudes were basically the same as in the
GSL group (P>. 05). In brief, GSL-treated eyes exhibited
more moderate loss in both a- and b-wave amplitudes
compared with MNU control (P<. 01, Figures 2(a) and
2(c)),andthelosswas statisticallysigniﬁcantlysimilar forthe
GSL group and FO group (P>. 05, Figures 2(a) and 2(c)).
3.2. GSL, Similar to FO, Inhibits Retina Damage Induced by
MNU Observed under Light Microscopy. As i n g l es y s t e m i c
administration of MNU evoked progressive retinal lesions
in all MNU treated rats, while NC rats retained normal
retinal appearance. As shown in Figure 3,c o m p a r e dw i t h
retinas from the NC group (Figures 3(a), 3(e),a n d3(i))
retinas from MNU-treated animals (Figures 3(b), 3(f),a n d
3(j)) showed an apparent reduction in ONL thickness and
distorted nuclear orientation. GSL treatment (Figures 3(c),
3(g),a n d3(k)) signiﬁcantly inhibited the retinal lesions
induced by MNU, as did FO treatment (Figures 3(d), 3(h),
and 3(l)).
Retina pathological score was evaluated by histopathol-
ogy (H-E staining) and scored (Figure 4). As shown in
Figure 4(a), MNU injection caused signiﬁcantly higher
scores than in the NC group (P<. 001).After treatment with
GSL, rats developed less retinal pathology than those in the
MNU group (P<. 001)but still higher than in the NC group
(P<. 001); disease scores of GSL-treated rats were similar to
those of FO treated rats (P = .98 versus GSL group, P<. 001
versus MNU group). Meanwhile, retina pathological score
was evaluated on days 1, 3, 5, 7, and 10 after MNU injection
(Figures 4(b)–4(f)). Scores from GSL- and FO-treated eyes
were signiﬁcantly lower than those of MNU-treated eyes at
days 3, 5, 7, and 10 (P<. 05). GSL- and FO-treated eyes did
not diﬀer signiﬁcantly in scores (P>. 05).
3.3. GSL, Similar to FO, Inhibits Retina Damage Induced by
MNU Observed under Electron Microscope. At all detected
time points, photoreceptor segments were intact (Figures
5(a), 5(i),a n d5(q)), and photoreceptor cell nuclei were
normal in appearance (Figures 5(e), 5(m),a n d5(u))i n
the NC group. On day 1 after MNU, in the MNU group,
photoreceptor segments were severely damaged and being
phagocyted (Figure 5(b)), and fragmented photoreceptor
cell nuclei were seen (Figure 5(f)). In the GSL group,
photoreceptor segments were mainly intact (Figure 5(c)),
and photoreceptor cell nuclei were less fragmented than in
the MNU group (Figure 5(g)). Similarly, in the FO group,
photoreceptorsegments were slightly damaged (Figure 5(d))
and photoreceptor cell nuclei were less fragmented than
in the MNU group (Figure 5(h)). On day 3 after MNU,
photoreceptor segments were completely damaged or lost
in the MNU group (Figure 5(j)), and plenty of fragmented
photoreceptor cell nuclei were seen (Figure 5(n)). In the
GSL group, photoreceptor segments were largely damaged
and lost (Figure 5(o)), and some photoreceptor cells were
damaged (Figure 5(k)); slightly more damage could be seen
in the FO group (Figures 5(l) and 5(p)) than in the GSL
group. On day 10 after MNU, photoreceptor segments were
completely lost in the MNU group (Figure 5(r)), and the
most of the photoreceptor cells were lost (Figure 5(v)). In
GSL- (Figures 5(s) and 5(w)) and FO-treated rats (Figures
5(t) and 5(x)), photoreceptor segments were disorganized,4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: The eﬀect of Ganoderma spores lipid (GSL) and ﬁsh oil (FO) on the decrease in a- and b-wave amplitude in N-methyl-N-
nitrosourea- (MNU-) induced retina damage in rats. (a) A-wave amplitudes of normal control (NC), MNU, GSL, and FO groups; (b)
a-wave amplitudes at each time point for NC, MNU, GSL, and FO groups; (c) b-wave amplitudes of NC, MNU, GSL, and FO groups; (d)
b-wave amplitudes at each time point for NC, MNU, GSL, and FO groups. After MNU, all eyes showed reductions in both a- and b-wave
amplitude compared with the NC group. In rats receiving GSL, both amplitudes decreased signiﬁcantly less than those of rats in the MNU
group, but no signiﬁcant change was found between the GSL group and the FO group. These data suggest that GSL, similar to FO, has a
protective eﬀect on MNU-damaged retinal ERG.
∗P <. 05 versus MNU,
∗∗P <. 01 versus MNU, #P <. 05 versus NC, ##P <. 01 versus NC.
and many photoreceptor cells were lost, but no fragmented
photoreceptor nuclei could be seen.
4.Discussion
The mechanism underlining MNU-induced retinal outer
nuclear layer damage is that MNU speciﬁcally targets the
retinal photoreceptor cell, restricting the inward turning of
nuclearDNA,resulting in apoptosis ofthe photoreceptorcell
[15, 16]. A single systemic administration of the alkylating
agent MNU in rats leads to apoptosis and photoreceptor
cell loss within approximately seven days [15]. We, therefore,
observed the performances of rats for 10 days after MNU.
In the dark-adapted ﬂash ERG, the a-wave primarily rep-
resents the mixed function of cones and rods, while b-wave
mainly reﬂects light-induced depolarization of bipolar cells
and the activity of other cells, including M¨ uller cells [17].
Firstly, we illustrated the protective eﬀects of GSL and FO
on retina by ERG assay. Our data showed that after daily
administration of GSL, rats exhibited more moderate loss in
both a- and b-wave amplitudes than rats that received only
MNU injection. The protective eﬀect of GSL on the retina
was not signiﬁcantly diﬀerent from that of FO. This result
suggests thatGSLhas thesame protectiveeﬀectasFOagainst
MNU-damaged retinal ERGs.
Secondly, our results show that GSL, like FO, protects
the retinal microstructure and ultrastructure against MNU-
induceddamage.Damagetotheratretinalphotoreceptorcell
inducedby MNUwas alleviated signiﬁcantly in the GSL-and
FO-treated groups, as observed by light microscopy. UnderEvidence-Based Complementary and Alternative Medicine 5
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Figure 3: The H-E staining photographs of rat retina treated with Ganoderma spores lipid (GSL) and ﬁsh oil (FO). (a, e, i) Normal control
(NC) group on days 1, 3, and 10, respectively; (b, f, j) N-methyl-N-nitrosourea (MNU) treated group on days 1, 3, and 10, respectively; (c,
g, k) GSL group on days 1, 3, and 10, respectively; (d, h, l) FO group on days 1, 3, and 10, respectively. A single systemic administration of
MNU evoked progressive retinal lesions. GSL and FO treatment caused inhibition of retinal lesions induced by MNU. GCL, ganglion cell
layer; IPL, inner plexiform layer; INL, inner nuclear layer; ONL, outer nuclear layer; OS, outer segment. Scale bar, 40μm.6 Evidence-Based Complementary and Alternative Medicine
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Figure 4:Therelative protection eﬀects ofGanodermaspores lipid(GSL)andﬁshoil(FO)asreﬂected bythepathologicalscoreofratretina.
(a)Retina pathologicalscores ofrats inthe normalcontrol (NC),N-methyl-N-nitrosourea (MNU), GSL,andFO group; (b) scores onday 1;
(c) scores on day 3; (d) scores on day 5; (e) scores on day 7; (f) scores on day 10. Retina pathological score was evaluated by histopathology
(H-E staining) on days 1, 3, 5, 7, and 10 after MNU injection. Each point represents the score of one rat (right eye). Scores from GSL- and
FO-treated eyes were signiﬁcantly lower than those from MNU-treated eyes on days 3, 5, 7, and 10 after MNU (P<. 05). There was no
signiﬁcantdiﬀerence in scores of GSL- and FO-treated eyes (P>. 05). The horizontalbar denotes the average of each group.
∗P <. 05 versus
MNU,
∗∗∗P <. 001 versus MNU, ###P <. 001 versus NC.
electron microscopy, GSL and FO were seen to reverse the
damage to photoreceptor segments and photoreceptor cell
nuclei induced by MNU.
The major fatty acid constituents of human retinal lipids
are palmitic (PA, 16:0n), stearic (SA, 18:0n), OA (18:1n-9),
arachidonic (ARA, 20:4n-6), and DHA (22:6n-3) [18]. It
does not diﬀer signiﬁcantly in fatty acid composition from
the vitamin A ester mixture (containing C12 to C18 fatty
acids) synthesized by the retinal tissue of other vertebrates
[19].Retinal neurons arehighly enriched inlipids containing
PUFAs, essential fatty acids that must be obtained from the
diet.DietsupplementationwithGSL,FO,orDHAinanimalsEvidence-Based Complementary and Alternative Medicine 7
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Figure 5: The protection eﬀect of Ganoderma spores lipid (GSL) and ﬁsh oil (FO) as shown by electron microscopy on days 1 (a–f), 3 (i–
p), and 10 (q–x) for normal control (NC) group (ﬁrst column) and eyes treated with N-methyl-N-nitrosourea (MNU, second column).
Retina in the GSL group (third column) showed milder damage in photoreceptor segments and less nuclear apoptosis than those in
MNU group. Retina in the FO group (fourth column) had the same characteristics with those in GLS group. Diamond arrow: pigment
epithelium nucleus. Black arrowhead: normal photoreceptor segments. White arrowhead: damaged photoreceptor segments. Black arrow:
normalnucleus in the outer nuclear layer. White arrow:apoptosis nucleus in the outer nuclear layer. Round arrow:Bruch’s membrane.Scale
bar, 1μm. Magniﬁcation:9700x. These suggest that both GSL and FO treatment can inhibit retinal lesions induced by MNU.
has the disadvantages of diﬃculty of accurately measuring
daily intake and susceptibility to oxidation. Therefore, we
used intragastric administration of GSL and FO in the
present study to avoid these disadvantages.
FO, containing high levels of DHA and eicosapentaenoic
acid (EPA, 20:5n-3), is known to inﬂuence membrane fatty
acid composition and to modulate the formation of eico-
sanoids in several tissues [20, 21]. There is a generally
accepted pathway for metabolism of EPA to DHA [22]. The
dietary intakeofn-3fatlyacidshasnotonlyimportantphysi-
ological consequences but also a therapeutic eﬀect on retinal
degeneration in vertebrate retina. Via binding to interpho-
toreceptor retinoid-binding protein, DHA release the 11-
cis-retinal and is taken up by the photoreceptor cell [23].
DHA seems to act as a trophic molecule in photoreceptor
survival both in vivo and in vitro [24]. Some studies have8 Evidence-Based Complementary and Alternative Medicine
found lower DHA content in an RP animal model and RP
patients [25, 26]. DHA supplementation of the diet of SD
rats with retinal photoreceptor apoptosis induced by MNU
both delayed the onset of photoreceptor cell apoptosis and
suppressed the progression of retinopathy [24, 27]. In rats
with retinal damage induce by kainic acid, increasing DHA
levelsin retinal and serum increased theb-waveamplitudeof
ERG and apparently also increasing the amount of ganglion
and the thickness of the inner nuclear cell layer [28]. The
FO we used in this research contained 70% n-3 PUFAs, of
which DHA accounted 54% and EPA for 7% (data provided
by Croda, UK).
Furthermore, FO contains both linoleic acid (LA, 18:2n-
6) and OA as well [29]. Retinal photoreceptors matrix is
high in OA [30], which was found to bind more tightly to
interphotoreceptor retinoid-binding protein than did DHA.
ButLAserves asasubstrate, andonceobtainedfrom thediet,
it can be further metabolized into ARA and EPA [31]. LA
and OA may both play a role in the FO inhibition of MNU-
induced retinal damage.
Potential therapeutic interventions using Ganoderma lu-
cidum spores have attracted extensive interest as studies have
suggested that extracts of these spores mediate neuronal
neuroprotection [32]. The major bioactive components in
Ganoderma lucidum spores are triterpenoids, polysaccha-
rides, fatty acids, and steroids, similar to the Ganoderma
itself [8], but their bioactivity may be much higher than that
of the whole mushroom [33, 34]. Moreover, GSL extracted
from sporoderm-broken spores by supercritical CO2 shows
even higher bioactivity than the whole spores [34]. Sixteen
fatty acids (C14 to C24) were identiﬁed in GSL provided
by Holistol International Ltd., of which PA accounted for
14.55%, and SA 5.03%, LA 12.20%, OA 61.17%, linolenic
acid 0.036%, and so forth (detected by China National Ana-
lytical Center, Guangzhou).
The neuroprotective mechanisms of FO are likely mul-
tifactorial, including prevention neuronal accumulation of
calcium, depletion activates caspase, inhibition of glutamin-
ergic transport, and neurotransmission involved excitotox-
icity [35, 36]. The ability of n-3 PUFA to reduce oxidative
stress may be an important component of its overall neu-
roprotective actions [5]. Lines of evidence also suggest
that n-3 PUFA can aﬀect the expression of many genes
in the central nervous system, number of which represent
transcriptionfactors[37].Furthermore,theprotectiveeﬀects
of n-3 PUFA may attribute to alteration of nerve cell lipid
composition and metabolism [38, 39]. In recent years, a
number of studies have been published illustrating the
potential protective eﬀects of n-3 supplementation in ocular
diseases such asage-related maculopathy[40].AndDHAcan
suppress photoreceptor cell apoptosis in the rat with MNU-
induced retinal degeneration [24, 27]. DHA can dramati-
cally increase diﬀerentiation in Crx-positive photoreceptor
cells, enhancing opsin expression, apical diﬀerentiation, and
axonal outgrowth [41].
Similarly, GSL riches in PUFAs, and companying by
other bioactive compositions exhibits the neuroprotective
eﬀects via antioxidative stress [9], increasing neuronal dif-
ferentiation [10], and preventing toxicity eﬀects on neurons
[11]. Cheung and colleagues [10] reported that Ganoderma
extract induced the neuronal diﬀerentiation of PC12 cells
from apoptosis, and the eﬀects may be mediated via the Ras/
Erk and cAMP-response element-binding protein signaling
pathways.Moreover, oxidativestress hasbeenlinkedwith the
pathogenesis of retinal degeneration. Ganoderma Lucidum
peptide is the major antioxidant component of Ganoderma
Lucidum and may be involved in the inhibition of lipid per-
oxidation through its antioxidant, metal chelating, and free
radical-scavenging activities [42]. The polysaccharides, also
major components of Ganoderma Lucidum, can eﬀectively
reduce oxidative injury and inhibit apoptosis by increasing
antioxidant enzyme activities and modifying Bcl-2 expres-
sion and Bax/Bcl-2 ratio [43].
Our previous study suggested that GSL may regulate the
expressions of Bax, Bcl-xl, and caspase-3, inhibiting MNU-
induced rat photoreceptor cell apoptosis and protecting reti-
nalfunctioninadose-dependentmanner[12].Inthepresent
paper, we compared the protective eﬀect of GSL and FO
on lesion of rat retinal visual function, photoreceptor cell
damage, and loss induced by MNU using electrophysiology
and morphology methods. Our data indicate that GSL is
similar to FO in alleviating the extent of rat retinal photo-
receptor cell damage induced by MNU.
Either GSL or FO contains a great number of PUFAs.
There are two major classes of PUFAs: n-3 (e.g., DHA, EPA,
and α-linolenic acid) and n-6 (e.g.,LA, ARA,and γ-linolenic
acid). Both n-3 and n-6 PUFAs play important roles in
neuronal growth, development of synaptic processing of
neuronal cell interaction, and expression of genes regulating
cell diﬀerentiation and growth [44]. Schaebelen and co-
workers [45] demonstrated that a 6-month supplementation
with a combination of n-3 (EPA and DHA) and n-6 PUFAs
(γ-linolenic acid) was more eﬀective than single supplemen-
tation, and the EPA+DHA+γ-linolenic acid dietary combi-
nation prevented retinal damage induced by the elevation
of intraocular pressure in rats. GSL and FO obtained from
Ganoderma lucidumand sea ﬁsh, respectively, are the nature
mixture of n-3 and n-6 PUFAs. So, these lines of evidence
support our results that GSL and FO have the same roles of
inhibition of retinal damage induced by MNU.
AlthoughGSL protects retina similar to FO,it has certain
advantages over FO. First, GSL can be obtained on a com-
mercial scale from Ganoderma lucidum farming, making
it a potentially cheap and plentiful substance. FO only can
be abstracted from sea ﬁsh. Increasing production and con-
sumption of GSL to substitute FO can avoid depending on
sea ﬁsh and relieve the burden of overﬁshing. Second, GSL
is well tolerated and has fewer side eﬀects than FO. It has
the potential to be useful to those who cannot take FO. This
additional beneﬁt of GSL in combating MNU-induced rat
photoreceptor cell apoptosis and protecting retinal function
indicates the need for further research into other potential
therapeutic applications.
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